Stephanie V Blank

4PUBLICATIONS
50CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 09, 2025
Maintenance therapy after first-line therapy for ovarian cancer: Quantitative effectiveness.

Susana M Campos, Jessica DiSilvestro, Stephanie V Blank

|Jul 01, 2025
Projected Trends in the Incidence and Mortality of Uterine Cancer in the United States.

Jason D Wright, Matthew T Prest, Jennifer S Ferris

|Oct 21, 2023
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.

Shannon N Westin, Kathleen Moore, Hye Sook Chon

|Jan 03, 2023
Influence of Genomic Landscape on Cancer Immunotherapy for Newly Diagnosed Ovarian Cancer: Biomarker Analyses from the IMagyn050 Randomized Clinical Trial.

Charles N Landen, Luciana Molinero, Habib Hamidi

Pageof 1